Determinants of incident vulvovaginal candidiasis in human immunodeficiency virus-positive women

Infectious Diseases in Obstetrics and Gynecology

Volumn 8, Issue 3-4, 2000, Pages 176-180

  Shifrin, Emma ^a   Matityahu, Debra ^a   Feldman, Joseph ^b   Minkoff, Howard ^a,c  

^a SUNY Downstate Medical Center   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c MAIMONIDES MEDICAL CENTER   (United States)

Author keywords

HIV serostatus; Immune status; Symptomatic candidiasis

Indexed keywords

ADULT; ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; VAGINA CANDIDIASIS;

EID: 0033852692     PISSN: 10647449     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-0997(2000)8:3/4<176::aid-idog14>3.0.co;2-q     Document Type: Article

References (7)

1. Duerr A, Sierra MF, Feldman J, et al. Immune compromise and prevalence of candida vulvovaginitis in human immunodeficiency virus-infected women. Obstet Gynecol 1997;90:252-256.
2. Spinillo A, Michelone G, Cavanna C, et al. Clinical and microbiological characteristics of symptomatic vulvovaginal candidiasis in HIV-seropositive women. Genitourin Med 1994;70:268-272.
3. White MH. Is vulvovaginal candidiasis an AIDS-related disease? Clin Infect Dis 1996;22 (suppl 2):S124-127.
4. Imam N, Carpenter CCJ, Mayer KH, et al. Hierarchical pattern of mucosal Candida infections in HIV-seropositive women. Am J Med 1990;89:142-146.
5. Chirgwin KD, Feldman J, Augenbraun M, et al. Incidence of venereal warts in human immunodeficiency virus-infected and uninfected women. J Infect Dis 1995;172:235-238.
6. Rhoads JL, Wright DC, Redfield RR, Burke DS. Chronic vaginal candidiasis in women with human immunodeficiency virus infection. JAMA 1987;257:3105-3107.
7. Minkoff H, Feldman J, Burke R, et al. The prevalence and incidence of gynecologic disease among HIV-infected and uninfected women. Am J Obstet Gynecol 1999;180:824-836.